Overview
Werner syndrome (also known as adult progeria or progeria of the adult) is a rare autosomal recessive disorder characterized by the premature appearance of features associated with aging. It is caused by mutations in the WRN gene (also called RECQL2), located on chromosome 8p12, which encodes a member of the RecQ family of DNA helicases involved in DNA repair, replication, and maintenance of genomic stability. The disease typically becomes apparent in the late teenage years or early twenties, when affected individuals fail to undergo the typical adolescent growth spurt, resulting in short stature. Key clinical features include bilateral cataracts (usually developing in the twenties), premature graying and thinning of the hair, scleroderma-like skin changes, subcutaneous tissue atrophy, and a characteristic aged facial appearance often described as "bird-like." Affected individuals frequently develop type 2 diabetes mellitus, hypogonadism, osteoporosis, atherosclerosis, and soft tissue calcifications. The voice may become high-pitched due to vocal cord atrophy. Skin ulcers, particularly around the ankles and Achilles tendon, are common and often difficult to treat. There is a significantly increased risk of malignancies, particularly soft tissue sarcomas, thyroid carcinomas, melanoma, meningiomas, and osteosarcomas, which are unusual in their distribution compared to the general population. The average life expectancy for individuals with Werner syndrome is approximately 54 years, with the most common causes of death being atherosclerotic cardiovascular disease and malignancy. There is currently no cure or treatment that reverses or halts the underlying accelerated aging process. Management is supportive and focused on surveillance and treatment of individual complications, including cataract surgery, management of diabetes and dyslipidemia, monitoring for malignancies, and wound care for skin ulcers. Werner syndrome is most prevalent in Japan, where the carrier frequency is estimated to be higher due to founder mutations.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventMOMA Therapeutics — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Werner syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Werner syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Werner syndrome.
Community
No community posts yet. Be the first to share your experience with Werner syndrome.
Start the conversation →Latest news about Werner syndrome
Disease timeline:
New recruiting trial: Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
A new clinical trial is recruiting patients for Werner syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Werner syndrome
What is Werner syndrome?
Werner syndrome (also known as adult progeria or progeria of the adult) is a rare autosomal recessive disorder characterized by the premature appearance of features associated with aging. It is caused by mutations in the WRN gene (also called RECQL2), located on chromosome 8p12, which encodes a member of the RecQ family of DNA helicases involved in DNA repair, replication, and maintenance of genomic stability. The disease typically becomes apparent in the late teenage years or early twenties, when affected individuals fail to undergo the typical adolescent growth spurt, resulting in short stat
How is Werner syndrome inherited?
Werner syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Werner syndrome typically begin?
Typical onset of Werner syndrome is adult. Age of onset can vary across affected individuals.
Which specialists treat Werner syndrome?
2 specialists and care centers treating Werner syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.